Ginkgo Bioworks Holdings, Inc. - 10-Q Filing

Ginkgo Bioworks reports Q3 2026 financial results including discontinued operations related to Tower Biosecurity Inc.

SEC EDGAR ·

Tickers: $DNA

Read the full article at SEC EDGAR

More Regulatory news